Why are HIV/AIDS patients in Indonesia concerned about a shortage of the TLE antiretroviral (ARV) drug in Indonesia? How did the shortage occur? How have the authorities responded to the shortage? This report from the team at KBR 68H examines the growing fears among Indonesian ODHA (people with HIV/AIDS) about the availability of their medication.
KBR 68H Report: HIV drug shortage fears
The fixed dose combination antiretroviral Tenofovir Lamivudin and Efavirenz . (Antara 11 January 2019). Source: (Antara 11 January 2019).
HIV/AIDS patients in Indonesia are concerned about a shortage of antiretroviral (ARV) drugs.
Share
